Grail

About:

Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.

Twitter/X: GrailBio

Top Investors: ARCH Venture Partners, Sutter Hill Ventures, Google Ventures, Illumina, HongShan

Description:

Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.

Total Funding Amount:

$2B

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

2016-01-01

Contact Email:

pr(AT)grail.com

Hub Tags:

Exited Unicorn